McKesson’s Board of Directors Elects Dr. Ken Washington as New Independent Director

IRVING, Texas–(BUSINESS WIRE)–McKesson Corporation (NYSE:MCK) today announced that its board of
directors elected Dr. Ken Washington as a new independent director,
effective July 1, 2019. With the election of Dr. Washington, McKesson’s
board of directors increases from nine to ten members, nine of whom are
independent.

Ken’s years of experience in technology, research, and privacy strategy
at complex global organizations will be invaluable to the board as we
maintain oversight of the company and provide the leadership team with
strategic guidance,” said Edward Mueller, McKesson’s independent board
chair. “He joins the McKesson board of directors at an exciting time as
the company drives forward its strategic growth initiative to transform
care delivery, deepen relationships with customers, and pursue
additional growth opportunities globally. We’re excited to welcome him.”

I’m honored to join McKesson’s board of directors and look forward to
working with my fellow board members and company leadership, advising on
the strategic direction of the company,” added Dr. Washington. “I’m
excited by the opportunity to help reshape the healthcare delivery
ecosystem by advancing technologies that can improve patient care.”

Dr. Ken Washington

Dr. Washington, age 58, has served as chief technology officer (CTO) of
Ford Motor Company since June 2017. In this role, he leads Ford’s
worldwide research organization, and oversees the development and
implementation of Ford’s technology strategy and plans. Prior to his
role as CTO, Dr. Washington was appointed Ford’s vice president of
Research and Advanced Engineering in August 2014.

Previously, Dr. Washington was vice president of the Advanced Technology
Center at Lockheed Martin Space Systems Company. He also served as
Lockheed Martin Corporation’s first chief privacy officer, a role in
which he built the company’s privacy program. In addition, he was
responsible for shaping the future of the Lockheed Martin’s information
technology enterprise as vice president and chief technology officer of
the internal IT organization. Before joining Lockheed Martin in February
2007, Dr. Washington was the chief information officer for Sandia
National Laboratories, where he held a variety of technical, management
and program leadership positions.

He has a bachelor’s, master’s and doctorate degree in nuclear
engineering from Texas A&M University and is a fellow of the MIT Seminar
XXI program on International Relations.

McKesson’s board has appointed Dr. Washington to its Compliance
Committee and its Finance Committee.

About McKesson Corporation

McKesson Corporation, currently ranked 7th on the FORTUNE 500, is a
global leader in healthcare supply chain management solutions, retail
pharmacy, healthcare technology, community oncology and specialty care.
McKesson partners with life sciences companies, manufacturers,
providers, pharmacies, governments and other healthcare organizations to
help provide the right medicines, medical products and healthcare
services to the right patients at the right time, safely and
cost-effectively. United by our ICARE shared principles, our employees
work every day to innovate and deliver opportunities to improve patient
care in every setting — one product, one partner, one patient at a time.
McKesson has been named a “Most
Admired Company
” in the healthcare wholesaler category by FORTUNE, a
Best
Place to Work
” by the Human Rights Campaign Foundation, and a top military-friendly
company
 by Military Friendly. For more information, visit www.mckesson.com.

Contacts

McKesson Corporation Contact:
Investors and Financial Media:
Holly
Weiss
972-969-9174
Holly.Weiss@McKesson.com

General and Business Media:
Kristin Chasen
415-983-8974
Kristin.Chasen@McKesson.com

McKesson’s Board of Directors Elects Dr. Ken Washington as New Independent Director

IRVING, Texas–(BUSINESS WIRE)–McKesson Corporation (NYSE:MCK) today announced that its board of
directors elected Dr. Ken Washington as a new independent director,
effective July 1, 2019. With the election of Dr. Washington, McKesson’s
board of directors increases from nine to ten members, nine of whom are
independent.

Ken’s years of experience in technology, research, and privacy strategy
at complex global organizations will be invaluable to the board as we
maintain oversight of the company and provide the leadership team with
strategic guidance,” said Edward Mueller, McKesson’s independent board
chair. “He joins the McKesson board of directors at an exciting time as
the company drives forward its strategic growth initiative to transform
care delivery, deepen relationships with customers, and pursue
additional growth opportunities globally. We’re excited to welcome him.”

I’m honored to join McKesson’s board of directors and look forward to
working with my fellow board members and company leadership, advising on
the strategic direction of the company,” added Dr. Washington. “I’m
excited by the opportunity to help reshape the healthcare delivery
ecosystem by advancing technologies that can improve patient care.”

Dr. Ken Washington

Dr. Washington, age 58, has served as chief technology officer (CTO) of
Ford Motor Company since June 2017. In this role, he leads Ford’s
worldwide research organization, and oversees the development and
implementation of Ford’s technology strategy and plans. Prior to his
role as CTO, Dr. Washington was appointed Ford’s vice president of
Research and Advanced Engineering in August 2014.

Previously, Dr. Washington was vice president of the Advanced Technology
Center at Lockheed Martin Space Systems Company. He also served as
Lockheed Martin Corporation’s first chief privacy officer, a role in
which he built the company’s privacy program. In addition, he was
responsible for shaping the future of the Lockheed Martin’s information
technology enterprise as vice president and chief technology officer of
the internal IT organization. Before joining Lockheed Martin in February
2007, Dr. Washington was the chief information officer for Sandia
National Laboratories, where he held a variety of technical, management
and program leadership positions.

He has a bachelor’s, master’s and doctorate degree in nuclear
engineering from Texas A&M University and is a fellow of the MIT Seminar
XXI program on International Relations.

McKesson’s board has appointed Dr. Washington to its Compliance
Committee and its Finance Committee.

About McKesson Corporation

McKesson Corporation, currently ranked 7th on the FORTUNE 500, is a
global leader in healthcare supply chain management solutions, retail
pharmacy, healthcare technology, community oncology and specialty care.
McKesson partners with life sciences companies, manufacturers,
providers, pharmacies, governments and other healthcare organizations to
help provide the right medicines, medical products and healthcare
services to the right patients at the right time, safely and
cost-effectively. United by our ICARE shared principles, our employees
work every day to innovate and deliver opportunities to improve patient
care in every setting — one product, one partner, one patient at a time.
McKesson has been named a “Most
Admired Company
” in the healthcare wholesaler category by FORTUNE, a
Best
Place to Work
” by the Human Rights Campaign Foundation, and a top military-friendly
company
 by Military Friendly. For more information, visit www.mckesson.com.

Contacts

McKesson Corporation Contact:
Investors and Financial Media:
Holly
Weiss
972-969-9174
Holly.Weiss@McKesson.com

General and Business Media:
Kristin Chasen
415-983-8974
Kristin.Chasen@McKesson.com

error: Content is protected !!